Sawai Group Holdings (TSE:4887): Fresh Valuation Insights After Major Asahi Kasei Patent Settlement

Sawai Group Holdings (TSE:4887) has closed the chapter on a major legal battle with Asahi Kasei Pharma. The company has agreed to a multi-billion yen settlement, officially ending the patent dispute over its generic teriparatide product.

See our latest analysis for Sawai Group Holdings.

The legal resolution arrived just as Sawai Group Holdings was working to reverse a challenging stretch for its share price. The stock remains down nearly 10% year-to-date despite some recent stability. While last year’s total shareholder return was essentially flat, the company’s three-year total return of nearly 50% highlights its longer-term momentum and ability to rebound when uncertainty fades.

If you’re curious where the next wave of growth could come from in this dynamic sector, it’s a great time to explore See the full list for free.

With the lawsuit now behind Sawai Group Holdings and shares trading at a meaningful discount to analyst targets, the question becomes whether the stock is undervalued at current levels or if the market has already priced in its future growth.

Price-to-Earnings of 16x: Is it justified?

Sawai Group Holdings is currently trading at a price-to-earnings (P/E) ratio of 16x, with shares closing at ¥1,935.5. This signals the market's valuation of its current and expected earnings compared to both industry and estimated fair value benchmarks.

The price-to-earnings ratio gauges how much investors are willing to pay for each yen of current earnings. For pharmaceuticals, where future profitability is closely tied to research pipelines and product launches, the P/E is often a key reference point for investors evaluating relative value.

Sawai’s current P/E of 16x is somewhat elevated compared to the Japanese Pharmaceuticals industry average of 15.3x. This suggests the market is pricing in either superior resilience or future growth. However, based on our assessment, the estimated fair P/E ratio is even higher at 18.9x, a level that could indicate room for the market to reevaluate Sawai’s earnings potential if forecasts play out as projected.

Explore the SWS fair ratio for Sawai Group Holdings

Result: Price-to-Earnings of 16x (ABOUT RIGHT)

However, slowing revenue growth and the stock’s year-to-date decline remain key risks. These factors could challenge any swift re-rating in the months ahead.

Find out about the key risks to this Sawai Group Holdings narrative.

Another View: Discounted Cash Flow Model

Looking through a different lens, our DCF model suggests Sawai Group Holdings may be trading well below its intrinsic value. The model estimates fair value at ¥3,567.15 per share, which is roughly 46% above the current price. Could the market be overlooking longer-term cash flow prospects?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Sawai Group Holdings for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Sawai Group Holdings Narrative

Whether you want to challenge these findings or take a hands-on approach to your research, you can easily craft your own investment story in just a few minutes. Do it your way

A great starting point for your Sawai Group Holdings research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Don’t wait on the sidelines while opportunities pass by. Make your next smart investing move and tap into untapped corners of the market using our powerful screeners:

• Capture high yields and steady returns by checking out these 17 dividend stocks with yields > 3% that offer robust dividends above 3%.
• Stay ahead of the market’s shifts by evaluating these 876 undervalued stocks based on cash flows with strong cash flow potential and the possibility of a re-rating.
• Capitalize on emerging growth by uncovering these 25 AI penny stocks at the forefront of artificial intelligence innovation and real-world adoption.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com